{"DataElement":{"publicId":"7433947","version":"1","preferredName":"Disease Response Domain Central Nervous System Disease Response Original Result Relapse Status Type","preferredDefinition":"An indicator for CNS relapse status.","longName":"RS_RSORRES_CNS_RLP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7411373","version":"1","preferredName":"Disease Response Domain Central Nervous System Disease Response Original Result","preferredDefinition":"A domain for disease response evaluations._The part of the nervous system that consists of the brain, spinal cord, and meninges._The outcome of the disease response assessment as originally received or collected.","longName":"6608777v1.0:7411371v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7411371","version":"1","preferredName":"Central Nervous System Disease Response Original Result","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.:The outcome of the disease response assessment as originally received or collected.","longName":"C12438:C117397","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response Original Result","conceptCode":"C117397","definition":"The outcome of the disease response assessment as originally received or collected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE4A4F44-F9A7-0385-E053-4EBD850A8EF0","latestVersionIndicator":"Yes","beginDate":"2020-09-01","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-01","modifiedBy":"ONEDATA","dateModified":"2020-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE4A4F44-F9B8-0385-E053-4EBD850A8EF0","latestVersionIndicator":"Yes","beginDate":"2020-09-01","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-01","modifiedBy":"SETRAKIN","dateModified":"2020-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6703301","version":"1","preferredName":"Relapse Status Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6703301v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Rel-M1","valueDescription":"Rel-M1","ValueMeaning":{"publicId":"6703466","version":"1","preferredName":"Rel-M1","longName":"6703466","preferredDefinition":"Rel-M1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D534AF-CF09-6CC6-E053-F662850AFE42","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8726389E-E447-16E9-E053-F662850A7D65","beginDate":"2019-04-22","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-22","modifiedBy":"ONEDATA","dateModified":"2019-04-22","deletedIndicator":"No"},{"value":"Rel-M2","valueDescription":"Rel-M2","ValueMeaning":{"publicId":"6703467","version":"1","preferredName":"Rel-M2","longName":"6703467","preferredDefinition":"Rel-M2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D534AF-CF2C-6CC6-E053-F662850AFE42","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8726389E-E451-16E9-E053-F662850A7D65","beginDate":"2019-04-22","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-22","modifiedBy":"ONEDATA","dateModified":"2019-04-22","deletedIndicator":"No"},{"value":"Rel-M3","valueDescription":"Rel-M3","ValueMeaning":{"publicId":"6703468","version":"1","preferredName":"Rel-M3","longName":"6703468","preferredDefinition":"Rel-M3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D534AF-CF4F-6CC6-E053-F662850AFE42","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8726389E-E45B-16E9-E053-F662850A7D65","beginDate":"2019-04-22","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-22","modifiedBy":"ONEDATA","dateModified":"2019-04-22","deletedIndicator":"No"},{"value":"Rel-CNS3c","valueDescription":"Rel-CNS3c","ValueMeaning":{"publicId":"6703302","version":"1","preferredName":"Rel-CNS3c","longName":"6703302","preferredDefinition":"Rel-CNS3c","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4B475-1422-65B6-E053-F662850ADB74","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87270569-07BF-69C6-E053-F662850AAC48","beginDate":"2019-04-22","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-22","modifiedBy":"ONEDATA","dateModified":"2019-04-22","deletedIndicator":"No"},{"value":"Rel-CNS3a/b","valueDescription":"Rel-CNS3a/b","ValueMeaning":{"publicId":"6703303","version":"1","preferredName":"Rel-CNS3a/b","longName":"6703303","preferredDefinition":"Rel-CNS3a/b","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4B475-1445-65B6-E053-F662850ADB74","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87270569-07C9-69C6-E053-F662850AAC48","beginDate":"2019-04-22","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-22","modifiedBy":"ONEDATA","dateModified":"2019-04-22","deletedIndicator":"No"},{"value":"Rel-CNS2","valueDescription":"Rel-CNS2","ValueMeaning":{"publicId":"6703304","version":"1","preferredName":"Rel-CNS2","longName":"6703304","preferredDefinition":"Rel-CNS2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4B475-1468-65B6-E053-F662850ADB74","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87270569-07D3-69C6-E053-F662850AAC48","beginDate":"2019-04-22","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-22","modifiedBy":"ONEDATA","dateModified":"2019-04-22","deletedIndicator":"No"},{"value":"M2 marrow with no positive confirmatory tests","valueDescription":"M2 marrow with no positive confirmatory tests","ValueMeaning":{"publicId":"7415670","version":"1","preferredName":"M2 marrow with no positive confirmatory tests","longName":"7415670","preferredDefinition":"M2 marrow with no positive confirmatory tests","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF105447-67A1-2497-E053-4EBD850ADB22","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF105447-67BA-2497-E053-4EBD850ADB22","beginDate":"2020-09-11","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"M1 marrow with no positive confirmatory tests","valueDescription":"M1 marrow with no positive confirmatory tests","ValueMeaning":{"publicId":"7415671","version":"1","preferredName":"M1 marrow with no positive confirmatory tests","longName":"7415671","preferredDefinition":"M1 marrow with no positive confirmatory tests","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF105447-67C4-2497-E053-4EBD850ADB22","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF105447-67DD-2497-E053-4EBD850ADB22","beginDate":"2020-09-11","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"CNS 1","valueDescription":"CNS 1","ValueMeaning":{"publicId":"3228396","version":"1","preferredName":"CNS 1","longName":"3228396","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there is an absence of blasts on a cerebral spinal fluid cytospin preparation, regardless of the number of white blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 1","conceptCode":"C116833","definition":"The status of central nervous system leukemia at diagnosis, where there is an absence of blasts on a cerebral spinal fluid cytospin preparation, regardless of the number of white blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16046E6-D7F1-1B8D-E040-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B012DBF9-979B-7490-E053-4EBD850AC11A","beginDate":"2020-09-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-24","modifiedBy":"ONEDATA","dateModified":"2020-09-24","deletedIndicator":"No"},{"value":"CNS 2 with no positive confirmatory tests","valueDescription":"CNS 2 with no positive confirmatory tests","ValueMeaning":{"publicId":"7433943","version":"1","preferredName":"CNS 2 with no positive confirmatory tests","longName":"7433943","preferredDefinition":"CNS 2 with no positive confirmatory tests","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0128021-5364-3C95-E053-4EBD850A00A1","latestVersionIndicator":"Yes","beginDate":"2020-09-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-24","modifiedBy":"ONEDATA","dateModified":"2020-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B0128021-537D-3C95-E053-4EBD850A00A1","beginDate":"2020-09-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-24","modifiedBy":"ONEDATA","dateModified":"2020-09-24","deletedIndicator":"No"},{"value":"M3","valueDescription":"M3: > 25% blasts in a bone marrow aspirate with at least 200 cells counted","ValueMeaning":{"publicId":"7446881","version":"1","preferredName":"M3: > 25% blasts in a bone marrow aspirate with at least 200 cells counted","longName":"7446881","preferredDefinition":"M3: > 25% blasts in a bone marrow aspirate with at least 200 cells counted","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0658355-4182-2C8C-E053-4EBD850A321F","latestVersionIndicator":"Yes","beginDate":"2020-09-28","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B0658355-419B-2C8C-E053-4EBD850A321F","beginDate":"2020-09-28","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","deletedIndicator":"No"},{"value":"M2","valueDescription":"M2: 5% - 25% blasts in a bone marrow aspirate with at least 200 cells counted","ValueMeaning":{"publicId":"7446882","version":"1","preferredName":"M2: 5% - 25% blasts in a bone marrow aspirate with at least 200 cells counted","longName":"7446882","preferredDefinition":"M2: 5% - 25% blasts in a bone marrow aspirate with at least 200 cells counted","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0658355-41A5-2C8C-E053-4EBD850A321F","latestVersionIndicator":"Yes","beginDate":"2020-09-28","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B0658355-41BE-2C8C-E053-4EBD850A321F","beginDate":"2020-09-28","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","deletedIndicator":"No"},{"value":"M1","valueDescription":"M1: < 5% blasts in a bone marrow aspirate with at least 200 cells counted","ValueMeaning":{"publicId":"7446883","version":"1","preferredName":"M1: < 5% blasts in a bone marrow aspirate with at least 200 cells counted","longName":"7446883","preferredDefinition":"M1: < 5% blasts in a bone marrow aspirate with at least 200 cells counted","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0658355-41C8-2C8C-E053-4EBD850A321F","latestVersionIndicator":"Yes","beginDate":"2020-09-28","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B0658355-41E1-2C8C-E053-4EBD850A321F","beginDate":"2020-09-28","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","deletedIndicator":"No"},{"value":"CNS 2","valueDescription":null,"ValueMeaning":{"publicId":"3228395","version":"1","preferredName":"CNS 2","longName":"3228395v1.00","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; or greater than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is considered negative by Steinherz/Bleyer algorithm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2","conceptCode":"C116834","definition":"The status of central nervous system leukemia at diagnosis, where there are less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; or greater than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is considered negative by Steinherz/Bleyer algorithm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16046E6-D7CE-1B8D-E040-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-20","modifiedBy":"MMADDINENI","dateModified":"2022-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF5DF015-54CB-2A5A-E053-731AD00A8826","beginDate":"2022-05-19","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-05-19","modifiedBy":"MMADDINENI","dateModified":"2022-05-19","deletedIndicator":"No"},{"value":"CNS 3","valueDescription":null,"ValueMeaning":{"publicId":"3228394","version":"1","preferredName":"CNS 3","longName":"3228394v1.00","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are more than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; with or without clinical signs of CNS leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 3","conceptCode":"C116835","definition":"The status of central nervous system leukemia at diagnosis, where there are more than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; with or without clinical signs of CNS leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16046E6-D7AB-1B8D-E040-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-20","modifiedBy":"MMADDINENI","dateModified":"2022-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF5DF015-54CC-2A5A-E053-731AD00A8826","beginDate":"2022-05-19","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-05-19","modifiedBy":"MMADDINENI","dateModified":"2022-05-19","deletedIndicator":"No"},{"value":"CNS 2a","valueDescription":null,"ValueMeaning":{"publicId":"4420568","version":"1","preferredName":"CNS 2a","longName":"4420568","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are less than 10 red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2a","conceptCode":"C116836","definition":"The status of central nervous system leukemia at diagnosis, where there are less than 10 red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5D7B-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6533B4D-1625-1641-E053-731AD00AFA7A","beginDate":"2023-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-07","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","deletedIndicator":"No"},{"value":"CNS 2b","valueDescription":null,"ValueMeaning":{"publicId":"4420569","version":"1","preferredName":"CNS 2b","longName":"4420569","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2b","conceptCode":"C116837","definition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5DA0-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6533B4D-1626-1641-E053-731AD00AFA7A","beginDate":"2023-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-07","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","deletedIndicator":"No"},{"value":"CNS 2c","valueDescription":null,"ValueMeaning":{"publicId":"4420570","version":"1","preferredName":"CNS 2c","longName":"4420570","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts and is considered negative by Steinherz/Bleyer algorithm","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2c","conceptCode":"C116838","definition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts and is considered negative by Steinherz/Bleyer algorithm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5DC5-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6533B4D-1627-1641-E053-731AD00AFA7A","beginDate":"2023-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-07","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D4B475-140D-65B6-E053-F662850ADB74","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-18","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RS_RSORRES_CNS_RLP_FDRC","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What is the definitive CNS relapse status?","url":null,"context":"COG"},{"name":"What was the CNS status?","type":"Preferred Question Text","description":"What was the CNS status?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"What was the CNS status at first relapse?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B012BF19-368E-7D51-E053-4EBD850A2EEE","latestVersionIndicator":"Yes","beginDate":"2020-09-24","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-24","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":null,"administrativeNotes":"2023.3.7 AQT/Alt Name added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"}}